ÂÜÀòÂÒÂ×

Micheline Wille has a diverse work experience spanning over several companies. Micheline is currently working as the VP Medical Affairs at GenSight Biologics since March 2023. Prior to that, they held the position of Vice President at Novartis Gene Therapies from September 2020 to March 2023. Before joining Novartis, Micheline was the VP Medical Affairs EMEA at AveXis, Inc. from January 2018 to September 2020. Micheline also served as the Vice President Medical Affairs EMEA at Horizon Pharma plc from October 2016 to December 2017, and previously as the VP Medical Affairs Europe at Raptor Pharmaceuticals from February 2015 to October 2016. Micheline has a history of working at Shire Pharmaceuticals, where they held the positions of Head of Medical Affairs, Europe from March 2014 to February 2015 and Senior Medical Director at the Shire Rare Disease Business Unit from April 2012 to March 2014. Prior to Shire Pharmaceuticals, they worked at Shire HGT as the Medical Director for European Mid-Sized Countries from January 2010 to April 2012. Micheline also has experience working at TiGenix, where they held various roles including Director of Medical Affairs from May 2008 to December 2009. Micheline had also worked at AstraZeneca as the Therapeutic Area Leader for CNS from February 2004 to June 2006. Micheline started their professional career as an Anesthesiologist at the Catholic University Leuven from August 1995 to August 2000.

Micheline Wille's education history includes a Doctor of Medicine (M.D.) degree from KU Leuven, which they obtained from 1986 to 2000. In 2012, they attended IMD to study Strategies for Leadership. Micheline also pursued an International Executive MBA at Vlerick Business School from 2008 to 2010. Additionally, Micheline Wille has additional unspecified education experience from KU Leuven and Vlerick Business School.